Eyal Ron

1.3k total citations
17 papers, 955 citations indexed

About

Eyal Ron is a scholar working on Biomedical Engineering, Surgery and Epidemiology. According to data from OpenAlex, Eyal Ron has authored 17 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 7 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Eyal Ron's work include Bone Tissue Engineering Materials (8 papers), Orthopaedic implants and arthroplasty (5 papers) and Bone fractures and treatments (4 papers). Eyal Ron is often cited by papers focused on Bone Tissue Engineering Materials (8 papers), Orthopaedic implants and arthroplasty (5 papers) and Bone fractures and treatments (4 papers). Eyal Ron collaborates with scholars based in United States, Italy and Germany. Eyal Ron's co-authors include Leslie J. Marden, Jeffrey O. Hollinger, Rainer H. Böger, Richard A. Kenley, Robert G. Schaub, Anshumali Chaudhari, Michael H. Mayer, John M. Wozney, J. O. Hollinger and Thomas J. Turek and has published in prestigious journals such as Journal of Controlled Release, Plastic & Reconstructive Surgery and Pharmaceutical Research.

In The Last Decade

Eyal Ron

17 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyal Ron United States 11 557 264 252 226 144 17 955
Jonas Jensen Denmark 21 236 0.4× 490 1.9× 219 0.9× 242 1.1× 312 2.2× 35 1.3k
Isabel F. Tresguerres Spain 16 235 0.4× 184 0.7× 214 0.8× 277 1.2× 141 1.0× 31 805
Stefan Zwingenberger Germany 18 435 0.8× 488 1.8× 114 0.5× 72 0.3× 200 1.4× 57 1.2k
J. Batten United Kingdom 13 559 1.0× 495 1.9× 39 0.2× 265 1.2× 117 0.8× 16 1.2k
Hiromitsu Toyoda Japan 25 428 0.8× 1.5k 5.5× 129 0.5× 63 0.3× 149 1.0× 134 2.1k
Daisuke Sato Japan 16 247 0.4× 289 1.1× 112 0.4× 416 1.8× 162 1.1× 53 979
Makoto Nakashima Japan 13 94 0.2× 330 1.3× 164 0.7× 132 0.6× 147 1.0× 39 1.1k
Khosrow Siamak Houschyar Germany 15 123 0.2× 210 0.8× 129 0.5× 106 0.5× 154 1.1× 49 889
Weidong Tong China 20 308 0.6× 647 2.5× 45 0.2× 130 0.6× 186 1.3× 91 1.3k
Yoichiro Ogino Japan 16 290 0.5× 312 1.2× 200 0.8× 330 1.5× 153 1.1× 52 986

Countries citing papers authored by Eyal Ron

Since Specialization
Citations

This map shows the geographic impact of Eyal Ron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Ron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Ron more than expected).

Fields of papers citing papers by Eyal Ron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Ron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Ron. The network helps show where Eyal Ron may publish in the future.

Co-authorship network of co-authors of Eyal Ron

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Ron. A scholar is included among the top collaborators of Eyal Ron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Ron. Eyal Ron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ron, Eyal, et al.. (2023). Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas. Cells. 12(21). 2575–2575. 8 indexed citations
2.
Ron, Eyal, et al.. (2021). Assessing the Cushion Effect: A Systematic Review and Meta-Analysis of the Role of Obesity in Motor Vehicle Injuries and Fatalities. Journal of Intensive Care Medicine. 37(3). 293–303. 8 indexed citations
3.
Ron, Eyal, et al.. (2021). Current Trends in the Use of Ultrasound Over Chest X-Ray to Identify Pneumothoraces in ICU, Trauma, and ARDS Patients. Journal of Intensive Care Medicine. 37(1). 5–11. 5 indexed citations
4.
Ron, Eyal, et al.. (2021). The Role of Obesity in Motor Vehicle Injuries and Fatalities in the Pediatric Population: A Systematic Review. Journal of Intensive Care Medicine. 37(4). 472–479. 1 indexed citations
5.
Urban, Lorien E., Eyal Ron, Alessandro Sannino, et al.. (2018). Effect of a nonsystemic, orally administered hydrogel, GS100, on metformin pharmacokinetics. Canadian Journal of Physiology and Pharmacology. 96(11). 1127–1131. 8 indexed citations
6.
Najafi, Bijan, et al.. (2017). Smarter Sole Survival: Will Neuropathic Patients at High Risk for Ulceration Use a Smart Insole-Based Foot Protection System?. Journal of Diabetes Science and Technology. 11(4). 702–713. 66 indexed citations
7.
Böger, Rainer H. & Eyal Ron. (2005). L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.. PubMed. 10(1). 14–23. 95 indexed citations
8.
Seiller, M., et al.. (2001). Study of the Breakup Under Shear of a New Thermally Reversible Water-in-Oil-in-Water (W/O/W) Multiple Emulsion. Pharmaceutical Research. 18(5). 689–693. 14 indexed citations
9.
Chaudhari, Anshumali, Eyal Ron, & Michael P. Rethman. (1997). Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Molecular and Cellular Biochemistry. 167(1-2). 31–39. 51 indexed citations
10.
Mayer, Michael H., et al.. (1996). Poly(α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. Journal of Controlled Release. 39(2-3). 287–304. 30 indexed citations
11.
Mayer, Michael H., Jeffrey O. Hollinger, Eyal Ron, & John M. Wozney. (1996). Maxillary Alveolar Cleft Repair in Dogs Using Recombinant Human Bone Morphogenetic Protein-2 and a Polymer Carrier. Plastic & Reconstructive Surgery. 98(2). 247–259. 96 indexed citations
12.
Smith, Jennifer L., Thomas F. Parsons, Thomas J. Turek, et al.. (1995). Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2). Journal of Controlled Release. 36(1-2). 183–195. 26 indexed citations
13.
Marden, Leslie J., et al.. (1994). Recombinant human bone morphogenetic protein‐2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. Journal of Biomedical Materials Research. 28(10). 1127–1138. 125 indexed citations
14.
Kenley, Richard A., et al.. (1994). Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein‐2 (rhBMP‐). Journal of Biomedical Materials Research. 28(10). 1139–1147. 159 indexed citations
15.
Shea, M., et al.. (1994). Healing of large segmental defects in rat femurs is aided by RhBMP‐2 in PLGA matrix. Journal of Biomedical Materials Research. 28(10). 1149–1156. 149 indexed citations
16.
Kenley, Richard A., et al.. (1993). Biotechnology and Bone Graft Substitutes. Pharmaceutical Research. 10(10). 1393–1401. 110 indexed citations
17.
Lane, Joseph M., et al.. (1992). Recombinant BMP-2 Bone Fracture Healing in a Rat Femoral Defect Model. Journal of Orthopaedic Trauma. 6(4). 511–511. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026